HURA
TuHURA Biosciences, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-31
Figures on this page computed 2026-11-08 13:20 UTC
Last close
1.72USD
Market data, 2026-11-04
Weekly closes, 2026-05-15 to 2026-11-04
Over that span: -25.5%
Except where said otherwise: 10-K for 2025, filed 2026-03-31
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-31
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-14
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-14
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-14
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Safety is the furthest below its sector's middle: 0.13 against 0.72 on the market's range.
- Growth-38.6%28 of 100, below its sector
- Returns on capital-143.6%7 of 100, below its sector
- Marginsn/anot placed
- Price3.7x26 of 100, below its sector
- Safety0.7813 of 100, below its sector
- What it pays outn/anot placed
- Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
3 of 5 readExcept where said otherwise: 10-K for 2025, filed 2026-03-31
- Salesn/a
Its own average over 3 years, 0.
- Profit2.29x
Its own average over 10 years, -13.1M.
- Free cash flow1.47x
Its own average over 5 years, -18.8M.
- Debtn/a
Its own average over 3 years, 252.0K.
- Price0.01x
Its own average over 11 years, 241. Market data, 2026-11-04
Profit is furthest from its own average, at 2.29 times.
The filed years, as a table
10Each line is 100 at 2016-06-30, the first year we hold.
| Filed year | Profit | Shares in issue |
|---|---|---|
| 2016-06-30 | 100.0 | 100.0 |
| 2017-06-30 | 91.2 | 110.0 |
| 2018-06-30 | 125.6 | 190.5 |
| 2019-06-30 | -90.8 | 235.2 |
| 2020-06-30 | -102.9 | 953.9 |
| 2021-06-30 | -432.0 | 2,364.3 |
| 2022-06-30 | -255.6 | 4,448.1 |
| 2023-12-31 | -330.7 | 1,900,363.0 |
| 2024-12-31 | -244.6 | 2,983,035.5 |
| 2025-12-31 | -339.0 | 7,660,660.2 |
How profit was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
How shares in issue was got
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
Figures behind the shape
Growth
-38.6%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
One-year change in net income-38.6%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Returns on capital
-143.6%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-14
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-14
Return on equity-143.6%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-14
Return on assets-109.9%
Net Income / Total Assets x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-14
Margins
n/aWe do not hold this figure for this company, so there is nothing to place.
wider is higher, with no cohort held
Gross marginn/a
We do not hold this figure for this company, so there is nothing to place.
Gross Profit / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
Operating marginn/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
Net marginn/a
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
Free cash flow marginn/a
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
Price
3.7xcheaper is higher, placed against 4,482 companies as of 2026-11-07
Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-31
Price to book3.7x10-Q for 2025, filed 2026-08-14
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-350451
- Reported in
- USD
- computed
- 10-Q for 2025, filed 2026-08-14
- computed
- 10-K for 2025, filed 2026-03-31
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-14
- 10-K for 2025, filed 2026-03-31
Price to sales ration/a
We do not hold this figure for this company, so there is nothing to place.
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
Safety
0.78safer is higher, placed against 4,231 companies as of 2026-11-07
Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- 10-K for 2025, filed 2026-03-31
- 10-Q for 2025, filed 2026-08-14
Current ratio0.7810-Q for 2025, filed 2026-08-14
Current Assets / Current Liabilities
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-350451
- Reported in
- USD
- 10-Q for 2025, filed 2026-08-14
- 10-Q for 2025, filed 2026-08-14
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
Altman Z-Scoren/a
We do not hold this figure for this company, so there is nothing to place.
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- Computed from the 10-K for 2025, filed 2026-03-31
- Computed from the 10-K for 2025, filed 2026-03-31
- Computed from the 10-K for 2025, filed 2026-03-31
- Computed from the 10-K for 2025, filed 2026-03-31
- Computed from the 10-K for 2025, filed 2026-03-31
What it pays out
n/aWe do not hold this figure for this company, so there is nothing to place.
more, and better covered, is higher, with no cohort held
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-134950
- Reported in
- USD
- 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
- Computed from the 10-K for 2025, filed 2026-03-31
- 10-K for 2025, filed 2026-03-31
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.